Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Sus scrofa | Calpain 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | calpain | Calpain 2 | 324 aa | 322 aa | 31.7 % |
Schistosoma mansoni | calpain (C02 family) | Calpain 2 | 324 aa | 318 aa | 24.2 % |
Plasmodium vivax | hypothetical protein, conserved | Calpain 2 | 324 aa | 277 aa | 19.9 % |
Echinococcus multilocularis | calpain | Calpain 2 | 324 aa | 320 aa | 31.9 % |
Echinococcus granulosus | calpain A | Calpain 2 | 324 aa | 297 aa | 27.6 % |
Schistosoma japonicum | Calpain-9, putative | Calpain 2 | 324 aa | 275 aa | 27.6 % |
Echinococcus multilocularis | hypothetical protein | Calpain 2 | 324 aa | 297 aa | 27.9 % |
Schistosoma mansoni | calpain C (C02 family) | Calpain 2 | 324 aa | 319 aa | 27.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0082 | 1 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0078 | 0.9322 | 0.9322 |
Brugia malayi | calpain family protein 1 | 0.0078 | 0.9322 | 1 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0082 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0873 | 0.0936 |
Brugia malayi | hypothetical protein | 0.0028 | 0.0873 | 0.0936 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0055 | 0.5373 | 0.5373 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0082 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3463 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.3463 | 0.3463 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0873 | 0.4424 |
Toxoplasma gondii | kringle domain-containing protein | 0.0035 | 0.1973 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.9322 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0035 | 0.1973 | 0.2117 |
Brugia malayi | hypothetical protein | 0.0043 | 0.3463 | 0.3714 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.3463 | 0.3463 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3463 | 1 |
Schistosoma mansoni | P2X receptor subunit | 0.0069 | 0.7774 | 0.7774 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0078 | 0.9322 | 1 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.1973 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1973 | 0.1973 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0035 | 0.1973 | 0.1973 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.3463 | 0.3463 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.9322 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0028 | 0.0873 | 0.4424 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.171 | 0.1835 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.433 | 0.4645 |
Echinococcus multilocularis | calpain A | 0.0082 | 1 | 1 |
Echinococcus multilocularis | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1973 | 0.2117 |
Brugia malayi | Kringle domain containing protein | 0.0035 | 0.1973 | 0.2117 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0028 | 0.0873 | 0.4424 |
Onchocerca volvulus | 0.0055 | 0.5373 | 1 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.433 | 0.4645 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3463 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0035 | 0.1973 | 0.2117 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.171 | 0.171 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.171 | 0.1835 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.5373 | 0.5764 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0035 | 0.1973 | 0.1973 |
Schistosoma mansoni | P2X receptor subunit | 0.0069 | 0.7774 | 0.7774 |
Schistosoma mansoni | P2X receptor subunit | 0.0069 | 0.7774 | 0.7774 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.1973 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0028 | 0.0873 | 0.4424 |
Brugia malayi | calpain family protein 1 | 0.0078 | 0.9322 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0055 | 0.5373 | 0.5764 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0035 | 0.1973 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.3463 | 0.3463 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.433 | 0.4645 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0082 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0028 | 0.0873 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0035 | 0.1973 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.433 | 0.4645 |
Echinococcus granulosus | p2X purinoceptor 4 | 0.0069 | 0.7774 | 0.7774 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.5373 | 0.5764 |
Schistosoma mansoni | P2X receptor subunit | 0.0069 | 0.7774 | 0.7774 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.3463 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 4.464390285 um | PUBCHEM_BIOASSAY: Dose Response Confirmation for Calpain Inhibitors. (Class of assay: confirmatory) [Related pubchem assays: 1236 (Primary screen preceding this confirmatory assay.)] | ChEMBL. | No reference |
Potency (functional) | 2.6169 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 5.6234 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.